HIGHLIGHTS
- who: Dennis Steenhuis and collaborators from the Department of Pharmacotherapy, Epidemiology, and Economics, University of, Research Institute have published the research: Role of Traditional Cardiovascular Risk Factors after Initiation of Statin Therapy: A PharmLines Inception Cohort Study, in the Journal: Cardiovascular ue020erapeutics of 24/05/2022
- what: Drug treatment for CVEs still occurs in patients on primary preventive statin therapy.
- how: In the Netherlands according to the Dutch College of General Practitioners (NHG) guidelines patients should receive statin therapy if the risk of experiencing a CVE in the next 10 years is more . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.